A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health
Cardiovascular disease (CVD) represents a significant financial burden on patients and families, compounded by both direct and indirect healthcare costs. The increasing prevalence of CVD, coupled with the rising costs of treatment, exacerbates financial toxicity—defined as the economic strain and as...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Houston Methodist DeBakey Heart & Vascular Center
2024-11-01
|
| Series: | Methodist DeBakey Cardiovascular Journal |
| Subjects: | |
| Online Access: | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1466 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850128311670276096 |
|---|---|
| author | Vijay Aaroha Kandula Grace Li Smith Ravi Rajaram Nicolas L. Palaskas Anita Deswal Khurram Nasir Hyeon-Ju Ryoo Ali |
| author_facet | Vijay Aaroha Kandula Grace Li Smith Ravi Rajaram Nicolas L. Palaskas Anita Deswal Khurram Nasir Hyeon-Ju Ryoo Ali |
| author_sort | Vijay Aaroha Kandula |
| collection | DOAJ |
| description | Cardiovascular disease (CVD) represents a significant financial burden on patients and families, compounded by both direct and indirect healthcare costs. The increasing prevalence of CVD, coupled with the rising costs of treatment, exacerbates financial toxicity—defined as the economic strain and associated physical, emotional, and behavioral consequences on patients. This review explores the scope of financial toxicity in CVD care, detailing its prevalence, associated risk factors, and the complex interplay with social determinants of health such as income, insurance status, and comorbidities. Drawing from models in oncology, we highlight key interventions aimed at mitigating financial toxicity, including patient counseling, financial navigation, and enhanced patient-physician cost discussions. By adopting these approaches, healthcare providers can better support patients with CVD in managing both their health and financial well-being, potentially improving clinical outcomes. Future research is needed to develop standardized assessment tools for financial toxicity in CVD and implement system-wide mitigation strategies. |
| format | Article |
| id | doaj-art-bcac2bb9fe894ba9ae4ea0b76f46f412 |
| institution | OA Journals |
| issn | 1947-6108 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Houston Methodist DeBakey Heart & Vascular Center |
| record_format | Article |
| series | Methodist DeBakey Cardiovascular Journal |
| spelling | doaj-art-bcac2bb9fe894ba9ae4ea0b76f46f4122025-08-20T02:33:23ZengHouston Methodist DeBakey Heart & Vascular CenterMethodist DeBakey Cardiovascular Journal1947-61082024-11-01205152610.14797/mdcvj.14661444A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of HealthVijay Aaroha Kandula0https://orcid.org/0009-0003-5789-8739Grace Li Smith1https://orcid.org/0000-0002-3171-2911Ravi Rajaram2https://orcid.org/0000-0003-2782-7756Nicolas L. Palaskas3https://orcid.org/0000-0001-7565-1797Anita Deswal4https://orcid.org/0000-0002-6147-9591Khurram Nasir5https://orcid.org/0000-0001-5576-5498Hyeon-Ju Ryoo Ali6https://orcid.org/0000-0002-3378-9154McGovern Medical School at UT Health Houston, Houston, TexasThe University of Texas MD Anderson Cancer Center, Houston, TexasThe University of Texas MD Anderson Cancer Center, Houston, TexasThe University of Texas MD Anderson Cancer Center, Houston, TexasThe University of Texas MD Anderson Cancer Center, Houston, TexasHouston Methodist Hospital, Houston, TexasThe University of Texas MD Anderson Cancer Center, Houston, TexasCardiovascular disease (CVD) represents a significant financial burden on patients and families, compounded by both direct and indirect healthcare costs. The increasing prevalence of CVD, coupled with the rising costs of treatment, exacerbates financial toxicity—defined as the economic strain and associated physical, emotional, and behavioral consequences on patients. This review explores the scope of financial toxicity in CVD care, detailing its prevalence, associated risk factors, and the complex interplay with social determinants of health such as income, insurance status, and comorbidities. Drawing from models in oncology, we highlight key interventions aimed at mitigating financial toxicity, including patient counseling, financial navigation, and enhanced patient-physician cost discussions. By adopting these approaches, healthcare providers can better support patients with CVD in managing both their health and financial well-being, potentially improving clinical outcomes. Future research is needed to develop standardized assessment tools for financial toxicity in CVD and implement system-wide mitigation strategies.https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1466financial toxicitycardiovascular diseasesocial determinants of health |
| spellingShingle | Vijay Aaroha Kandula Grace Li Smith Ravi Rajaram Nicolas L. Palaskas Anita Deswal Khurram Nasir Hyeon-Ju Ryoo Ali A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health Methodist DeBakey Cardiovascular Journal financial toxicity cardiovascular disease social determinants of health |
| title | A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health |
| title_full | A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health |
| title_fullStr | A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health |
| title_full_unstemmed | A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health |
| title_short | A Costly Cure: Understanding and Addressing Financial Toxicity in Cardiovascular Disease Health Care Within the Domain of Social Determinants of Health |
| title_sort | costly cure understanding and addressing financial toxicity in cardiovascular disease health care within the domain of social determinants of health |
| topic | financial toxicity cardiovascular disease social determinants of health |
| url | https://account.journal.houstonmethodist.org/index.php/up-j-mdbcj/article/view/1466 |
| work_keys_str_mv | AT vijayaarohakandula acostlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT gracelismith acostlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT ravirajaram acostlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT nicolaslpalaskas acostlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT anitadeswal acostlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT khurramnasir acostlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT hyeonjuryooali acostlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT vijayaarohakandula costlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT gracelismith costlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT ravirajaram costlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT nicolaslpalaskas costlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT anitadeswal costlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT khurramnasir costlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth AT hyeonjuryooali costlycureunderstandingandaddressingfinancialtoxicityincardiovasculardiseasehealthcarewithinthedomainofsocialdeterminantsofhealth |